Phase II, Safety and Immunogenicity of RAZI Cov Pars (RCP) SARS Cov-2 Vaccine in Adults Aged 18–70 Years; A Randomized, Double-Blind Clinical Trial
- Resource Type
- Article
- Authors
- Mohazzab, Arash; Fallah Mehrabadi, Mohammad Hossein; Es-haghi, Ali; Kalantari, Saeed; Mokhberalsafa, Ladan; Setarehdan, Seyed Amin; Sadeghi, Fariba; Rezaei Mokarram, Ali; Haji Moradi, Monireh; Razaz, Seyad Hossein; Taghdiri, Maryam; Ansarifar, Akram; Lotfi, Mohsen; Khorasani, Akbar; nofeli, Mojtaba; Masoumi, Safdar; Boluki, Zahra; Erfanpoor, Saeed; Bagheri Amiri, Fahimeh; Esmailzadehha, Neda; Filsoof, Sara; Mohseni, Vahideh; Ghahremanzadeh, Neda; Safari, Shiva; Shahsavan, Masoumeh; Bayazidi, Shnoo; Raghami Derakhshani, Maryam; Rabiee, Mohammad Hasan; Golmoradi-Zadeh, Rezvan; Khodadoost, Behnam; Solaymani-Dodaran, Masoud; Banihashemi, Seyed Reza
- Source
- In Journal of Pharmaceutical Sciences December 2023 112(12):3012-3021
- Subject
- Language
- ISSN
- 0022-3549